March, 2004Sponsored by Aventis Oncology
In this Issue

March is Colorectal Cancer Awareness Month  
Please see OncoLink's Colorectal Cancer Menu for more helpful information.

Feature Article:  
A new monoclonal antibody is approved for the treatment of advanced colon cancer
Senior Editor, Julia Draznin Maltzman, MD discusses Cetuximab (Erbitux).

Ask The Experts  
This is your chance to "Ask the OncoLink Experts" everything you've always wanted to know about cancer. Recent questions include:

New Treatment – ERBITUX  
Associate Editor, Ryan P. Smith, MD tells you what you need to know about Cetuximab (Erbitux).

OncoLink Poll
OncoLink Monthly Poll
How would you rate your first experience at the Oncologist office?
OncoLink Survey
eNewsletter Survey
We are looking for your input on our eNewsletter. Please take a moment to fill-out this anonymous survey.
OncoLink Colorectal Cancer

OncoLink Patient Guide: Colorectal Cancer
New Colorectal Cancer Book Available from the Editors of OncoLink

OncoLink News Flash
Virtual Colonoscopy: What is it and should everyone get one?
Senior Editor, Julia Draznin Maltzman, MD debates the pros and cons of this promising technology.

OncoLink Editors Choice
March Editors' Choice
Colorectal Cancer Network is intended to assist people with cancer, their family, friends and caregivers find the information to help them make decisions regarding treatment and management of their disease.
Contact Us   |   Unsubscribe   |   Privacy Policy